---
title: BC95 – Advanced Bowel Cancer Testing Service
url: https://edxmedical.co.uk/product/bc95-advanced-bowel-cancer-testing-service/
date: 2026-02-03T18:19:34+00:00
modified: 2026-04-09T11:08:10+00:00
lang: en_US
---

# BC95 – Advanced Bowel Cancer Testing Service

## Overview

BC95 is a clinician-led bowel cancer testing service designed to support structured assessment of colorectal cancer risk using complementary, evidence-based tests.

The services integrate stool-based screening and hereditary risk assessment to provide a broad clinical view than any single test alone.

BC95 is intended to support clinical decision-making and appropriate referrals, not to replace diagnostic investigation.

## What is BC95?

BC95 brings together:

- Stool DNA methylation test (EarlyTect®)
- Hereditary cancer risk assessment using multi-gene germline testing
- Quantitative faecal immunochemical testing (qFIT)

By combining these approaches, BC95 supports assessment of:

- Current bowel cancer risk
- Occult bleeding
- Inherited predisposition

## Availability through EDX Medical

BC95 is available in the UK through **EDX Medical** as an integrated testing service.

For ordering information, turnaround times, and pathway integration, please contact EDX Medical at [info@edxmedical.com](mailto:info@edxmedical.com).

## Tests included in BC95

### EarlyTect® - Stool DNA Methylation test

EarlyTect® analyses abnormal methylation of SC2 gene in stool-derived DNA, a biomarker associated with colorectal cancer.

[EarlyTect® - Stool DNA Methylation test](https://edxmedical.co.uk/product/earlytect-stool-dna-test-for-colorectal-cancer-screening/)

### Hereditary Cancer Testing

Hereditary Cancer testing assess inherited genetic variants associated with colorectal and related cancer risk using multi-gene NGS panels, provided by BGI Genomics.

[Hereditary Cancer Testing](https://edxmedical.co.uk/product/hereditary-cancer-testing-multi-gene-germline-panel/)

### qFIT – Quantitative Immunochemical Test

qFit measures the concentration of human haemoglobin in stool and is widely used in colorectal cancer screening and triage pathways

[qFIT – Quantitative Immunochemical Test](https://edxmedical.co.uk/product/qfit-quantitative-faecal-immunochemical-test/)

## FAQs

BC95 is an advanced bowel cancer testing service that integrates multiple complementary tests to support structured assessment of colorectal cancer risk.

No. BC95 supports risk assessment and referral decisions. Colonoscopy remains the diagnostic reference.

Test selection within BC95 may vary depending on clinical context and assessment.

Bc95 may be considered where a broader, multiple complementary tests are needed to support assessment of bowel cancer risk.
